Cargando…

Pharmacological vs Exercise Stress Echocardiography for Detection of Cardiac Allograft Vasculopathy

OBJECTIVE: To test the hypothesis that exercise and dobutamine would provide levels of cardiac stress that are comparable to those achieved in a general stress test population, and to one another, in heart transplant recipients. PATIENTS AND METHODS: From February 10, 2015, to December 31, 2017, 81...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gebska, Milena A., Williford, Noah N., Schadler, Angela J., Laxson, Carolyn, Alvarez, Paulino, Briasoulis, Alexandros, Cadaret, Linda M., Yumul-Non, Ily Kristine T., Kerber, Richard E., Weiss, Robert M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011003/ https://www.ncbi.nlm.nih.gov/pubmed/32055772 http://dx.doi.org/10.1016/j.mayocpiqo.2019.09.003

Ejemplares similares

Cardiac allograft vasculopathy diagnosed by vasodilator myocardial contrast echocardiography perfusion imaging
por: Prasad, Pooja, et al.
Publicado: (2023)

Diagnostic Accuracy of Dobutamine Stress Echocardiography for Detection of Cardiac Allograft Vasculopathy in Orthotopic Heart Transplant Patients
por: Mahmoodurrahman, Mohammed, et al.
Publicado: (2021)

Coronary Spasm and Polymorphic Ventricular Tachycardia One Year After Takotsubo
por: Williford, Noah N., et al.
Publicado: (2019)

Risk factors of cardiac allograft vasculopathy
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015)

Timing of 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients
por: Asleh, Rabea, et al.
Publicado: (2018)

Early Cardiac Allograft Vasculopathy: Are the Viruses to Blame?
por: Aggarwal, Ashim, et al.
Publicado: (2012)

Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis
por: Skorić, Boško, et al.
Publicado: (2014)

Coronary CTA for Surveillance of Cardiac Allograft Vasculopathy
por: Shah, Nishant R., et al.
Publicado: (2018)

The role of everolimus in treatment of cardiac allograft vasculopathy
por: Watanabe, Tetsu
Publicado: (2013)

The novel proteomic signature for cardiac allograft vasculopathy
por: Wei, Dongmei, et al.
Publicado: (2022)

What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?
por: Kobashigawa, Jon
Publicado: (2000)

Cardiac allograft vasculopathy in Dutch heart transplant recipients
por: Galli, G., et al.
Publicado: (2016)

Correction to: Coronary CTA for Surveillance of Cardiac Allograft Vasculopathy
por: Shah, Nishant R., et al.
Publicado: (2018)

Effect of Statin Intensity on the Progression of Cardiac Allograft Vasculopathy
por: Ellimuttil, Tracey M, et al.
Publicado: (2021)

Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy
por: Miller, Christopher A, et al.
Publicado: (2014)

A reproducible mouse model of chronic allograft nephropathy with vasculopathy
por: Zarjou, Abolfazl, et al.
Publicado: (2012)

Cardiac Allograft Vasculopathy: A Donor or Recipient Induced Pathology?
por: van den Hoogen, Patricia, et al.
Publicado: (2015)

Far-Infrared Therapy Decreases Orthotopic Allograft Transplantation Vasculopathy
por: Lin, Yi-Wen, et al.
Publicado: (2022)

Vascular rejection in cardiac allograft vasculopathy: Impact on graft survival
por: Nair, Nandini
Publicado: (2022)

Epicardial fat volume is related to the degree of cardiac allograft vasculopathy
por: Roest, Stefan, et al.
Publicado: (2022)

Factors associated with cardiac allograft vasculopathy after heart transplantation
por: Szczurek-Wasilewicz, Wioletta, et al.
Publicado: (2022)

Is Ambulatory Hemodynamic Monitoring Beneficial to Patients With Advanced Heart Failure?
por: Briasoulis, Alexandros, et al.
Publicado: (2021)

Interleukin 21 (IL-21) regulates chronic allograft vasculopathy (CAV) in murine heart allograft rejection
por: Khattar, Mithun, et al.
Publicado: (2019)

A 31-Year-Old Man With Angina Pectoris Resulting From Large Vessel Vasculitis
por: Statz, Giselle M., et al.
Publicado: (2021)

Neutrophil mediated smooth muscle cell loss precedes allograft vasculopathy
por: King, Chelsey L, et al.
Publicado: (2010)

Quantitative coronary computed tomography angiography for the detection of cardiac allograft vasculopathy
por: Foldyna, Borek, et al.
Publicado: (2020)

Melatonin Synergizes With Mesenchymal Stromal Cells Attenuates Chronic Allograft Vasculopathy
por: Qin, Ya-fei, et al.
Publicado: (2021)

Multiparametric Cardiac Magnetic Resonance Imaging for Diagnosing Cardiac Allograft Vasculopathy
por: Lee, Ji Won
Publicado: (2022)

Small Molecule Tyrosine Kinase Inhibitor Nintedanib Reduces Development of Cardiac Allograft Vasculopathy in Murine Aortic Allografts
por: Gocht, Annika, et al.
Publicado: (2018)

Association of CD14(+) monocyte-derived progenitor cells with cardiac allograft vasculopathy
por: Salama, Mohamed, et al.
Publicado: (2011)

Reduced Progression of Cardiac Allograft Vasculopathy with Routine Use of Induction Therapy with Basiliximab
por: Wang, Ricardo, et al.
Publicado: (2015)

Association of Intimal Neovessels Noted by Optical Coherence Tomography with Cardiac Allograft Vasculopathy
por: Chahal, Diljon S, et al.
Publicado: (2020)

Corrigendum: Melatonin Synergizes With Mesenchymal Stromal Cells Attenuates Chronic Allograft Vasculopathy
por: Qin, Ya-fei, et al.
Publicado: (2021)

Coronary allograft vasculopathy managed by Flash ostial balloon in a pediatric patient
por: Desai, Viral K., et al.
Publicado: (2021)

Women Hospitalized for Acute on Chronic Decompensated Systolic Heart Failure Receive Less Furosemide Compared to Men
por: Rasmussen, Tyler P., et al.
Publicado: (2019)

T(mem) time: Memory T-Cells in Cardiac Allograft Vasculopathy: Editorial to: “Memory T Cells Mediate Cardiac Allograft Vasculopathy and are Inactivated by Anti-OX40L Monoclonal Antibody” by Hao Wang et al.
por: Seidman, Michael A.
Publicado: (2014)

Allograft or Recipient ST2 Deficiency Oppositely Affected Cardiac Allograft Vasculopathy via Differentially Altering Immune Cells Infiltration
por: Zhang, Zhenggang, et al.
Publicado: (2021)

Early innate immune events induced by prolonged cold ischemia exacerbate allograft vasculopathy
por: Devitt, Jennifer J, et al.
Publicado: (2011)

Do LDE-Methotrexate lipid nanoparticles decrease allograft vasculopathy in rabbit transplanted heart ?
por: Stolf, N, et al.
Publicado: (2013)

Early Inflammatory Markers Are Independent Predictors of Cardiac Allograft Vasculopathy in Heart-Transplant Recipients
por: Labarrere, Carlos A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_v0is5ruf4fgla0nli4fik1p0pn